Type 1 interferonopathies

Clinical trials for Type 1 interferonopathies explained in plain language.

Never miss a new study

Get alerted when new Type 1 interferonopathies trials appear

Sign up with your email to follow new studies for Type 1 interferonopathies, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug hope for rare childhood immune disorders

Disease control Recruiting now

This early-stage trial tests a new medicine called IMSB301 in people with rare diseases where the immune system attacks the body. The study includes up to 6 participants aged 12 and older. The main goal is to check if the drug is safe and how it behaves in the body.

Matched conditions: TYPE 1 INTERFERONOPATHIES

Phase 1 • Sponsor: ImmuneSensor Therapeutics Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC

Type 1 interferonopathies

Get alerted when new Type 1 interferonopathies trials appear

New drug hope for rare childhood immune disorders